Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Lo Andrew, Director. Insider active across 3 companies, notably AbCellera Biologics Inc.. In total, 7 disclosures have been published. Breakdown: 2 buys · 2 sells. Total volume traded: €6.7m. Activity tracked since 3 December 2021. The latest transaction was filed on 17 November 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Lo Andrew is Administrateur and serves as a director at BridgeBio Pharma, Inc., Roivant Sciences Ltd. and AbCellera Biologics Inc. The 7 filings recorded cover the most recent filings we hold, from 2021-12-07 to 2026-06-24, with EUR 1,146,461 of buys and EUR 5,518,974 of sells in that sample.